綜醫研控股
2385
GIG Works
2375
note
5243
Renascience
4889
ReYuu Japan
9425
(FY)2024/03/31 | (Q4)2024/03/31 | (Q3)2023/12/31 | (Q2)2023/09/30 | (Q1)2023/06/30 | (FY)2023/03/31 | (Q4)2023/03/31 | (Q3)2022/12/31 | (Q2)2022/09/30 | (Q1)2022/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 9.73%84.83億 | -2.08%21.45億 | 19.79%20.48億 | 13.78%23.31億 | 9.94%19.59億 | 10.03%77.31億 | 31.10%21.9億 | 8.92%17.1億 | 3.31%20.49億 | -1.14%17.82億 |
主營業務成本 | 7.02%57.34億 | -9.33%14.62億 | 17.95%13.96億 | 12.32%15.56億 | 12.20%13.2億 | 10.95%53.58億 | 36.16%16.13億 | 8.99%11.84億 | 2.16%13.85億 | -2.20%11.76億 |
毛利 | 15.85%27.49億 | 18.17%6.83億 | 23.93%6.52億 | 16.82%7.75億 | 5.56%6.39億 | 8.01%23.73億 | 18.78%5.78億 | 8.78%5.26億 | 5.80%6.64億 | 0.98%6.06億 |
營業費用 | 0.70%17.77億 | -2.33%4.24億 | 2.15%4.57億 | 0.46%4.56億 | 2.50%4.4億 | 5.80%17.64億 | 9.80%4.34億 | 6.83%4.47億 | 4.40%4.54億 | 2.47%4.29億 |
營業利潤 | 59.74%9.73億 | 80.27%2.58億 | 146.54%1.96億 | 52.16%3.2億 | 13.00%1.99億 | 14.97%6.09億 | 57.90%1.43億 | 21.24%7,936.4萬 | 8.96%2.1億 | -2.47%1.76億 |
營業外利息收入與支出淨額 | 6.70%-20.9萬 | 0.00%-5.3萬 | 3.64%-5.3萬 | 14.04%-4.9萬 | 8.47%-5.4萬 | 7.05%-22.4萬 | 8.62%-5.3萬 | 6.78%-5.5萬 | 8.06%-5.7萬 | 4.84%-5.9萬 |
營業外利息收入 | 0.00%4,000 | 0.00%1,000 | 0.00%1,000 | 0.00%2,000 | --0 | 0.00%4,000 | 0.00%1,000 | 0.00%1,000 | 0.00%2,000 | --0 |
營業外利息支出 | -6.58%21.3萬 | 0.00%5.4萬 | -3.57%5.4萬 | -13.56%5.1萬 | -8.47%5.4萬 | -6.94%22.8萬 | -8.47%5.4萬 | -6.67%5.6萬 | -7.81%5.9萬 | -4.84%5.9萬 |
投資淨收益 | -14.16%3,081.1萬 | -27.50%1,038.2萬 | 1.48%590.8萬 | -23.11%759.5萬 | 17.93%692.6萬 | -7.02%3,589.3萬 | -47.26%1,432萬 | 37.47%582.2萬 | 290.13%987.8萬 | 25.30%587.3萬 |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | 0 | 0 | 0 | -21.1萬 | 0 | 0 | ||||
聯營企業及其他參股權益產生的收益 | ||||||||||
特殊收入(費用) | -840.80%-483萬 | -14,876.74%-635.4萬 | 364.54%65.5萬 | 139.52%65.2萬 | 101.96%4.3萬 | -48.35%14.1萬 | ||||
減:其他特殊費用 | 840.80%483萬 | 14,876.74%635.4萬 | -364.54%-65.5萬 | ---- | ---- | 23.47%-65.2萬 | 86.13%-4.3萬 | 48.35%-14.1萬 | ---- | ---- |
其他營業外收入(費用) | -96.65%95.6萬 | -353.17%-1,955.7萬 | -1.74%863.8萬 | 22.56%574.2萬 | -16.65%613.3萬 | 15.41%2,855.9萬 | 34.91%772.5萬 | 3.33%879.1萬 | -23.20%468.5萬 | 66.81%735.8萬 |
稅前利潤 | 48.37%10億 | 46.82%2.43億 | 124.12%2.11億 | 48.47%3.34億 | 12.01%2.12億 | 13.95%6.74億 | 36.22%1.65億 | 19.96%9,406.3萬 | 11.51%2.25億 | -0.17%1.89億 |
所得稅 | 55.34%3.07億 | 115.56%6,575萬 | 111.16%6,755.4萬 | 43.26%1.08億 | 9.80%6,535.9萬 | 3.36%1.98億 | -14.40%3,050.2萬 | 16.40%3,199.2萬 | 8.14%7,548.4萬 | 2.33%5,952.4萬 |
除稅後利潤 | 45.48%6.93億 | 31.28%1.77億 | 130.80%1.43億 | 51.10%2.26億 | 13.01%1.47億 | 19.01%4.76億 | 57.24%1.35億 | 21.88%6,207.1萬 | 13.29%1.49億 | -1.27%1.3億 |
持續經營利潤 | 45.48%6.93億 | 31.28%1.77億 | 130.80%1.43億 | 51.10%2.26億 | 13.02%1.47億 | 19.01%4.76億 | 57.24%1.35億 | 21.88%6,207.1萬 | 13.29%1.49億 | -1.27%1.3億 |
歸屬于少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 45.48%6.93億 | 31.28%1.77億 | 130.80%1.43億 | 51.10%2.26億 | 13.01%1.47億 | 19.01%4.76億 | 57.24%1.35億 | 21.88%6,207.1萬 | 13.29%1.49億 | -1.27%1.3億 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | 45.48%6.93億 | 31.28%1.77億 | 130.80%1.43億 | 51.10%2.26億 | 13.01%1.47億 | 19.01%4.76億 | 57.24%1.35億 | 21.88%6,207.1萬 | 13.29%1.49億 | -1.27%1.3億 |
總派息金額 | ||||||||||
基本每股收益 | 47.50%62.45 | 31.68%15.96 | 127.29%12.91 | 53.74%20.34 | 17.06%13.24 | 21.84%42.34 | 62.25%12.12 | 27.93%5.68 | 15.55%13.23 | -0.70%11.31 |
稀釋每股收益 | 47.25%61.67 | 31.55%15.76 | 127.09%12.74 | 53.40%20.08 | 16.88%13.09 | 21.64%41.88 | 62.11%11.98 | 27.50%5.61 | 15.43%13.09 | -0.88%11.2 |
每股派息 | 50.00%15 | 100.00%10 | 0 | 0.00%5 | 0 | 0.00%10 | 0.00%5 | 0 | 0.00%5 | 0 |
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |